Over 130 novel vaccine delivery devices, including marketed / under development products, are being investigated for the delivery of both liquid and solid formulations of vaccines claims Roots Analysis

Written by

Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine delivery systems, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration.

 

To order this 500+ page report, which features 90+ figures and 160+ tables, please visit https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html

 

The USD 1.5 billion (by 2030) financial opportunity within the novel vaccine delivery devices market has been analyzed across the following segments:

  • Type of device
  • Electroporation-based needle free injection system
  • Oral delivery systems
  • Nasal delivery systems
  • Jet injectors
  • Microneedle patches
  • Microinjectors

 

  • Route of administration
  • Oral
  • Intramuscular
  • Intranasal
  • Intradermal
  • Subcutaneous

 

  • Type of vaccine
  • Bivalent Oral Polio Vaccine
  • BCG Vaccine
  • DTP-HepB-Hib Vaccine
  • Pneumococcal Conjugate Vaccine
  • Influenza Vaccine
  • Measles Vaccine
  • Tetanus-Diphtheria Vaccine
  • Others

 

  • Key geographical regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

 

The Novel Vaccine Delivery Devices Market, 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • 3M
  • Becton Dickinson
  • Consort Medical
  • D’Antonio Consultants International
  • Enesi Pharma
  • Ichor Medical
  • Iconovo
  • Inovio Pharmaceuticals
  • PharmaJet
  • Union Medico

 

Table of Contents

 

  1. PREFACE

  2. EXECUTIVE SUMMARY

 

  1. INTRODUCTION

 

  1. MARKET LANDSCAPE

 

  1. DEVICE COMPETITIVENESS ANALYSIS

  2. TECHNOLOGY EFFECTIVENESS ANALYSIS

  3. NOVEL VACCINE DELIVERY DEVICES: LIKELY VACCINE CANDIDATES

  4. COMPANY PROFILES

  5. PARTNERSHIPS AND COLLABORATIONS

 

  1. SWOT ANALYSIS

 

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS

 

  1. EXECUTIVE INSIGHTS

  2. CONCLUDING REMARKS

  3. APPENDIX I: TABULATED DATA

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email [email protected]

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

 

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Article Tags:
· · ·
Article Categories:
Health

Leave a Reply

Your email address will not be published. Required fields are marked *